Description: PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Home Page: www.kalbe.co.id
Gedung KALBE
Jakarta,
10510
Indonesia
Phone:
62 21 4287 3888
Officers
| Name | Title |
|---|---|
| Mr. . Vidjongtius | President Director |
| Ms. Lanny Soputro | Director of Human Resources, General Affairs & HSSE |
| Mr. Sie Djohan | Director of Corporate Business Development, Management System & Regulatory Affairs and Director |
| Mr. Rustam Tan | Head of Internal Audit Unit |
| Maria Teresa Fabiola | Corporate Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Metals & Mining |
| GIC Sub-Industry: | Diversified Metals & Mining |
| Forward PE: | 17.7936 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.7821 |
| Price-to-Sales TTM: | 0.0001 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 12924 |